(2005). 5’ diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site. Mol Cell Biochem
(1999). Bodmer WF: Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: The predominant role of hMLH1. Proc Natl Acad Sci USA
(2007). Broad but distinct role of pregnane X receptor on the expression of individual cytochrome P450 in human hepatocytes. Drug Metab Pharmacokinet
(2008). Bulun SE: CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activityMol Cell. Endocrinol
(2002). Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA
(1987). CpG islands in vertebrate genomes.
(2006). DC: Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines. Pharmacogenet Genomics
(2001). E: Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol
(2010). Evrard A: Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. Mol Cancer
(2010). Explaining inter-individual variability in phenotype: Is epigenetics up to the challenge? Epigenetics
(2006). Identification of regulatory sites in the human PXR (NR1I2) promoter region. Mol Cell Biochem
(2004). Kivistö KT: Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther
(2008). Krasowski MD: PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics
(1999). LS: Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos
(2005). Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res
(1997). PW: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res
(2009). S: CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers.
(1996). T: A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique. Lab Invest
(2008). The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol Endocrinol
(2009). The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl Recept Signal
(2009). Tian Y: Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1.
(2010). Tian Y: Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells.
(2002). TM: The nuclear pregnane X receptor: ak e yr e g u l a t o ro fx e n o b i o t i cm e t a b o l i s m .Endocr Rev
(2006). Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR. Drug Metab Dispos
(1993). Two nuclear signalling pathways for vitamin D. Nature